258 related articles for article (PubMed ID: 37227124)
1. Preclinical Models of Laryngeal Papillomavirus Infection: A Scoping Review.
King RE; Bilger A; Rademacher J; Lambert PF; Thibeault SL
Laryngoscope; 2023 Dec; 133(12):3256-3268. PubMed ID: 37227124
[TBL] [Abstract][Full Text] [Related]
2. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
3. The Larynx is Protected from Secondary and Vertical Papillomavirus Infection in Immunocompetent Mice.
King RE; Rademacher J; Ward-Shaw ET; Hu R; Bilger A; Blaine-Sauer S; Spurgeon ME; Thibeault SL; Lambert PF
Laryngoscope; 2024 May; 134(5):2322-2330. PubMed ID: 38084790
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus types causing recurrent respiratory papillomatosis in Zimbabwe.
Matinhira N; Soko ND; Bandason T; Jenson RG; Dzongodza T; von Buchwald C; Chidziva C
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():147-152. PubMed ID: 30554686
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinical implications of low-risk human papillomavirus among patients with recurrent respiratory papillomatosis in Rio de Janeiro, Brazil.
Figueiredo MC; Justino MC; Delmonico L; Silvestre RT; de Castro TL; Dos Santos Moreira A; Macedo JMB; da Costa Carvalho MDG; Scherrer L; de Medeiros Lima DJM; Alves G; Ornellas MH
Auris Nasus Larynx; 2019 Aug; 46(4):570-575. PubMed ID: 30581074
[TBL] [Abstract][Full Text] [Related]
6. Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia.
Omland T; Lie KA; Akre H; Sandlie LE; Jebsen P; Sandvik L; Nymoen DA; Bzhalava D; Dillner J; Brøndbo K
PLoS One; 2014; 9(6):e99114. PubMed ID: 24918765
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract].
Velyvyte D; Laiskonis A; Uloza V; Gozdzicka-Jozefiak A
Medicina (Kaunas); 2002; 38(5):499-504. PubMed ID: 12474680
[TBL] [Abstract][Full Text] [Related]
8. Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.
Intakorn P; Sonsuwan N
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S136-41. PubMed ID: 25391185
[TBL] [Abstract][Full Text] [Related]
9. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
Ilboudo M; Zohoncon TM; Traore IMA; Traore EMA; Kande A; Obiri-Yeboah D; Djigma FW; Gyebre YMC; Simpore J
Am J Otolaryngol; 2019; 40(3):368-371. PubMed ID: 30799210
[TBL] [Abstract][Full Text] [Related]
10. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer.
Reidy PM; Dedo HH; Rabah R; Field JB; Mathog RH; Gregoire L; Lancaster WD
Laryngoscope; 2004 Nov; 114(11):1906-9. PubMed ID: 15510012
[TBL] [Abstract][Full Text] [Related]
11. The role of human papillomavirus in oncogenic transformation and its contribution to the etiology of precancerous lesions and cancer of the larynx: A review.
Nowińska K; Ciesielska U; Podhorska-Okołów M; Dzięgiel P
Adv Clin Exp Med; 2017; 26(3):539-547. PubMed ID: 28791831
[TBL] [Abstract][Full Text] [Related]
12. Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11.
Bonagura VR; Hatam LJ; Rosenthal DW; de Voti JA; Lam F; Steinberg BM; Abramson AL
APMIS; 2010 Jun; 118(6-7):455-70. PubMed ID: 20553528
[TBL] [Abstract][Full Text] [Related]
13. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
Hirai R; Makiyama K; Matsuzaki H; Oshima T
J Voice; 2018 Jul; 32(4):488-491. PubMed ID: 28866231
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infections in laryngeal cancer.
Torrente MC; Rodrigo JP; Haigentz M; Dikkers FG; Rinaldo A; Takes RP; Olofsson J; Ferlito A
Head Neck; 2011 Apr; 33(4):581-6. PubMed ID: 20848441
[TBL] [Abstract][Full Text] [Related]
15. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
16. Multi-Year Effect of Human Papillomavirus Vaccination on Recurrent Respiratory Papillomatosis.
Matsuzaki H; Makiyama K; Hirai R; Suzuki H; Asai R; Oshima T
Laryngoscope; 2020 Feb; 130(2):442-447. PubMed ID: 30963598
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus (HPV) in head and neck cancer.
Syrjänen S
J Clin Virol; 2005 Mar; 32 Suppl 1():S59-66. PubMed ID: 15753013
[TBL] [Abstract][Full Text] [Related]
18. HPV RNA in-situ hybridization as a diagnostic aid in papillary laryngeal lesions.
Garcia JA; Best SR; Rooper LM
Laryngoscope; 2020 Apr; 130(4):955-960. PubMed ID: 31283030
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and molecular biology studies of respiratory papillomatosis].
Mahnke CG; Werner JA; Fröhlich O; Lippert BM; Hoffmann M; Rudert HH
Laryngorhinootologie; 1998 Mar; 77(3):157-64. PubMed ID: 9577823
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset recurrent respiratory papillomatosis: a review of disease pathogenesis and implications for patient counseling.
Taliercio S; Cespedes M; Born H; Ruiz R; Roof S; Amin MR; Branski RC
JAMA Otolaryngol Head Neck Surg; 2015 Jan; 141(1):78-83. PubMed ID: 25393901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
